365 related articles for article (PubMed ID: 28688954)
1. Rifampicin-induced injury in HepG2 cells is alleviated by TUDCA via increasing bile acid transporters expression and enhancing the Nrf2-mediated adaptive response.
Zhang W; Chen L; Feng H; Wang W; Cai Y; Qi F; Tao X; Liu J; Shen Y; Ren X; Chen X; Xu J; Shen Y
Free Radic Biol Med; 2017 Nov; 112():24-35. PubMed ID: 28688954
[TBL] [Abstract][Full Text] [Related]
2. The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid/rifampicin-induced hepatotoxicity.
Guo YX; Xu XF; Zhang QZ; Li C; Deng Y; Jiang P; He LY; Peng WX
Toxicol Mech Methods; 2015; 25(5):382-7. PubMed ID: 25886055
[TBL] [Abstract][Full Text] [Related]
3. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA prevents rifampicin-induced liver injury by regulating BSEP/NTCP expression via epigenetic activation of NRF2.
Yang Y; Liu L; Zhang X; Jiang X; Wang L
Liver Int; 2020 Jan; 40(1):141-154. PubMed ID: 31571363
[TBL] [Abstract][Full Text] [Related]
5. The role of Ntcp, Oatp2, Bsep and Mrp2 in liver injury induced by Dioscorea bulbifera L. and Diosbulbin B in mice.
Qu XY; Tao LN; Zhang SX; Sun JM; Niu JQ; Ding YH; Song YQ
Environ Toxicol Pharmacol; 2017 Apr; 51():16-22. PubMed ID: 28262508
[TBL] [Abstract][Full Text] [Related]
6. Hepatobiliary transporter expression and post-operative jaundice in patients undergoing partial hepatectomy.
Bernhardt GA; Zollner G; Cerwenka H; Kornprat P; Fickert P; Bacher H; Werkgartner G; Müller G; Zatloukal K; Mischinger HJ; Trauner M
Liver Int; 2012 Jan; 32(1):119-27. PubMed ID: 22098322
[TBL] [Abstract][Full Text] [Related]
7. Regulation of hepatic drug transporter activity and expression by organochlorine pesticides.
Bucher S; Le Vee M; Jouan E; Fardel O
J Biochem Mol Toxicol; 2014 Mar; 28(3):119-28. PubMed ID: 24464585
[TBL] [Abstract][Full Text] [Related]
8. Rifampicin-induced injury in L02 cells is alleviated by 4-PBA via inhibition of the PERK-ATF4-CHOP pathway.
Zhang W; Chen L; Shen Y; Xu J
Toxicol In Vitro; 2016 Oct; 36():186-196. PubMed ID: 27470132
[TBL] [Abstract][Full Text] [Related]
9. Low dose of oleanolic acid protects against lithocholic acid-induced cholestasis in mice: potential involvement of nuclear factor-E2-related factor 2-mediated upregulation of multidrug resistance-associated proteins.
Chen P; Zeng H; Wang Y; Fan X; Xu C; Deng R; Zhou X; Bi H; Huang M
Drug Metab Dispos; 2014 May; 42(5):844-52. PubMed ID: 24510383
[TBL] [Abstract][Full Text] [Related]
10. Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride.
Geier A; Kim SK; Gerloff T; Dietrich CG; Lammert F; Karpen SJ; Stieger B; Meier PJ; Matern S; Gartung C
J Hepatol; 2002 Aug; 37(2):198-205. PubMed ID: 12127424
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes.
Jigorel E; Le Vee M; Boursier-Neyret C; Parmentier Y; Fardel O
Drug Metab Dispos; 2006 Oct; 34(10):1756-63. PubMed ID: 16837569
[TBL] [Abstract][Full Text] [Related]
12. Short-term feedback regulation of bile salt uptake by bile salts in rodent liver.
Mühlfeld S; Domanova O; Berlage T; Stross C; Helmer A; Keitel V; Häussinger D; Kubitz R
Hepatology; 2012 Dec; 56(6):2387-97. PubMed ID: 22806967
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.
Kok T; Bloks VW; Wolters H; Havinga R; Jansen PL; Staels B; Kuipers F
Biochem J; 2003 Feb; 369(Pt 3):539-47. PubMed ID: 12381268
[TBL] [Abstract][Full Text] [Related]
14. Optimized Hepatocyte-Like Cells with Functional Drug Transporters Directly-Reprogrammed from Mouse Fibroblasts and their Potential in Drug Disposition and Toxicology.
Wu ZT; Yao D; Ji SY; Ni X; Gao YM; Hui LJ; Pan GY
Cell Physiol Biochem; 2016; 38(5):1815-30. PubMed ID: 27160211
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of BSEP and MRP2 May Play an Important Role in Isoniazid-Induced Liver Injury via the SIRT1/FXR Pathway in Rats and HepG2 Cells.
Qu X; Zhang Y; Zhang S; Zhai J; Gao H; Tao L; Song Y
Biol Pharm Bull; 2018; 41(8):1211-1218. PubMed ID: 30068870
[TBL] [Abstract][Full Text] [Related]
16. Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells.
Ulvestad M; Nordell P; Asplund A; Rehnström M; Jacobsson S; Holmgren G; Davidson L; Brolén G; Edsbagge J; Björquist P; Küppers-Munther B; Andersson TB
Biochem Pharmacol; 2013 Sep; 86(5):691-702. PubMed ID: 23856292
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.
Lepist EI; Gillies H; Smith W; Hao J; Hubert C; St Claire RL; Brouwer KR; Ray AS
PLoS One; 2014; 9(1):e87548. PubMed ID: 24498134
[TBL] [Abstract][Full Text] [Related]
18. Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human liver drug transporters.
Han YH; Busler D; Hong Y; Tian Y; Chen C; Rodrigues AD
Drug Metab Dispos; 2010 Jul; 38(7):1072-82. PubMed ID: 20360302
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
Hartman JC; Brouwer K; Mandagere A; Melvin L; Gorczynski R
Can J Physiol Pharmacol; 2010 Jun; 88(6):682-91. PubMed ID: 20628435
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular organic anion-transporting polypeptides (OATPs) and multidrug resistance-associated protein 2 (MRP2) are inhibited by silibinin.
Wlcek K; Koller F; Ferenci P; Stieger B
Drug Metab Dispos; 2013 Aug; 41(8):1522-8. PubMed ID: 23695864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
